{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:59:41Z","timestamp":1779890381121,"version":"3.53.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.tube.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T12:28:12Z","timestamp":1228393692000},"page":"54-61","source":"Crossref","is-referenced-by-count":32,"title":["Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene"],"prefix":"10.1016","volume":"89","author":[{"given":"Shi","family":"Changhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Limei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Jiaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Tingfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhikai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2008.09.005_bib1","series-title":"Tuberculosis-fact sheet no.104","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.tube.2008.09.005_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00003495-200059020-00002","article-title":"Drug-resistant tuberculosis: what do we do now","volume":"59","author":"Telenti","year":"2000","journal-title":"Drug"},{"key":"10.1016\/j.tube.2008.09.005_bib3","first-page":"1008","article-title":"The epidemiology of HIV-associated tuberculosis in rural Cambodia","volume":"11","author":"Cain","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2008.09.005_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/pmj.76.895.259","article-title":"Impact of HIV on tuberculosis","volume":"76","author":"Zumla","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.tube.2008.09.005_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2008.09.005_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/156652407780831557","article-title":"Current strategies in TB immunotherapy","volume":"7","author":"Roy","year":"2007","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.tube.2008.09.005_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/bmj.39463.640787.BE","article-title":"Long term efficacy of DOTS regimens for tuberculosis: systematic review","volume":"336","author":"Cox","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.tube.2008.09.005_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0264-410X(97)00073-X","article-title":"Protection against tuberculosis by a plasmid DNA vaccine","volume":"15","author":"Lowrie","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/22326","article-title":"Therapy of tuberculosis in mice by DNA vaccination","volume":"400","author":"Lowrie","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.tube.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/107999000312450","article-title":"Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo","volume":"20","author":"Kim","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.tube.2008.09.005_bib11","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/S0264-410X(03)00378-5","article-title":"Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65","volume":"21","author":"Baek","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2008.09.005_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.0105-2896.2004.00200.x","article-title":"The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses","volume":"202","author":"Barouch","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tube.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1166\/jnn.2005.210","article-title":"Expression of the recombinant fusion protein CP15-23 of Cryptosporidium parvum and its protective test","volume":"5","author":"Hong-Xuan","year":"2005","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.tube.2008.09.005_bib14","article-title":"Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris","volume":"12","author":"Huang","year":"2007","journal-title":"J Pept Sci"},{"key":"10.1016\/j.tube.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/14787210.5.5.857","article-title":"Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control","volume":"5","author":"Matteelli","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.tube.2008.09.005_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/gt.2008.13","article-title":"Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83","volume":"9","author":"Yu","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.tube.2008.09.005_bib17","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1016\/j.vaccine.2005.05.035","article-title":"Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection","volume":"23","author":"Zhu","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.gt.3302418","article-title":"Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice","volume":"12","author":"Silva","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.tube.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1128\/IAI.72.3.1685-1692.2004","article-title":"Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis","volume":"72","author":"Derrick","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2007.00545.x","article-title":"Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?","volume":"219","author":"Berrington","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tube.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.2204027","article-title":"CD8+ T cells in tuberculosis","volume":"166","author":"Lazarevic","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.4049\/jimmunol.167.12.6991","article-title":"CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection","volume":"167","author":"Serbina","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2008.09.005_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2008.09.005_bib24","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/IAI.73.8.5189-5193.2005","article-title":"Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA","volume":"73","author":"Taylor","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2008.09.005_bib25","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/eji.1830230908","article-title":"Selective activation of resting human gamma delta T lymphocytes by interleukin-2","volume":"23","author":"Kjeldsen-Kragh","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2008.09.005_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0962-8479(97)90026-5","article-title":"rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo","volume":"78","author":"Johnson","year":"1997","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.tube.2008.09.005_bib27","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","article-title":"Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis","volume":"67","author":"Kamath","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2008.09.005_bib28","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.vaccine.2003.12.030","article-title":"Vaccine adjuvant: it makes the difference","volume":"22","author":"Lima","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2008.09.005_bib29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.vaccine.2006.09.089","article-title":"Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene","volume":"25","author":"Zhang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2008.09.005_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/IAI.74.1.557-565.2006","article-title":"Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection","volume":"74","author":"Wozniak","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2008.09.005_bib31","first-page":"1","article-title":"Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming","volume":"22","author":"Goncalves","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.tube.2008.09.005_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/156652305774329230","article-title":"Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines","volume":"5","author":"Xing","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.tube.2008.09.005_bib33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/IAI.71.4.2192-2198.2003","article-title":"Pulmonary necrosis resulting from DNA vaccination against tuberculosis","volume":"71","author":"Taylor","year":"2003","journal-title":"Infect Immun"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979208000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979208000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T20:36:36Z","timestamp":1589315796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979208000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1472979208000978"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2008.09.005","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}